AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10851920 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV screening offered on a routine basis in antenatal care since 1987, with 96% of pregnant women screened.
Number of subjects: 0
Study 10851920 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV screening during a period of two years.
Number of subjects: 0
Study 10851920 — intervention group
Group type: COMPARATOR
Intervention: Doctors and midwives involved in antenatal care.
Number of subjects: 0
Study 9100722 — intervention group
Group type: EXPERIMENTAL
Intervention: Advance directives with specific instructions to forgo life-sustaining treatment
Number of subjects: 4804
Study 9100722 — intervention group
Group type: COMPARATOR
Intervention: Advance directives without specific instructions
Number of subjects: 4804
Study 1589134 — intervention group
Group type: EXPERIMENTAL
Intervention: High hydration (2 lt/m2)
Number of subjects: 2
Study 1589134 — intervention group
Group type: COMPARATOR
Intervention: Low hydration (1.5 lt/m2)
Number of subjects: 2
Study 3157396 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil 20 micrograms kg‐1, followed by 50 micrograms at 30-min intervals
Number of subjects: 20
Study 3157396 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl 100 micrograms kg‐1, followed by 250 micrograms at 30-min intervals
Number of subjects: 20
Study 31412913 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious game 'You & I'
Number of subjects: 172
Study 31412913 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 172
Study 27904951 — intervention group
Group type: EXPERIMENTAL
Intervention: Peri-articular multimodal drug injection (bupivacaine hydrochloride, morphine sulphate, epinephrine, and ketorolac)
Number of subjects: 137
Study 27904951 — intervention group
Group type: COMPARATOR
Intervention: Control group (epinephrine only)
Number of subjects: 137
Study 27904951 — intervention group
Group type: EXPERIMENTAL
Intervention: Peri-articular multimodal drug injection
Number of subjects: 137
Study 26497391 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma-focused cognitive behavioral therapy (TF-CBT)
Number of subjects: 6
Study 23414498 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief motivational feedback (BMF)
Number of subjects: 84
Study 23414498 — intervention group
Group type: COMPARATOR
Intervention: Intake assessment as usual (AAU)
Number of subjects: 84
Study 21928867 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment entry
Number of subjects: 163
Study 21928867 — intervention group
Group type: EXPERIMENTAL
Intervention: During treatment
Number of subjects: 163
Study 21928867 — intervention group
Group type: EXPERIMENTAL
Intervention: Posttreatment
Number of subjects: 163
Study 21928867 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall alcohol use
Number of subjects: 163
Study 21928867 — intervention group
Group type: EXPERIMENTAL
Intervention: Latent alcohol use growth factors
Number of subjects: 163
Study 19330295 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent radiochemotherapy (RTCT) with cisplatin 20 mg/m(2) x 5 days
Number of subjects: 566
Study 19330295 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy (RT) alone
Number of subjects: 566
Study 19330295 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery after RT or RTCT
Number of subjects: 566
Study 19330295 — intervention group
Group type: COMPARATOR
Intervention: Nonoperated patients
Number of subjects: 566
Study 17765156 — intervention group
Group type: EXPERIMENTAL
Intervention: Open tension-free repair (TFR)
Number of subjects: 0
Study 17765156 — intervention group
Group type: COMPARATOR
Intervention: Watchful waiting (WW)
Number of subjects: 0
Study 15700913 — intervention group
Group type: EXPERIMENTAL
Intervention: Active nicotine patch
Number of subjects: 94
Study 15700913 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT group
Number of subjects: 94
Study 15700913 — intervention group
Group type: COMPARATOR
Intervention: Placebo nicotine patch
Number of subjects: 94
Study 15700913 — intervention group
Group type: COMPARATOR
Intervention: Non-HRT group
Number of subjects: 94
Study 12139546 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane titrated with AAItrade mark‐index (target AAItrade mark‐index of 20+/‐5)
Number of subjects: 30
Study 12139546 — intervention group
Group type: COMPARATOR
Intervention: Desflurane titrated according to routine clinical signs (control group)
Number of subjects: 30
Study 9579151 — intervention group
Group type: EXPERIMENTAL
Intervention: L-tyrosine (100 mg/kg body weight/d)
Number of subjects: 21
Study 9579151 — intervention group
Group type: COMPARATOR
Intervention: L-alanine (placebo)
Number of subjects: 21
Study 7543651 — intervention group
Group type: EXPERIMENTAL
Intervention: IV infusion of porcine galanin 500 micrograms in 100 mL saline
Number of subjects: 13
Study 7543651 — intervention group
Group type: EXPERIMENTAL
Intervention: IV injection of GHRH (1-29)NH2 1 microgram/kg plus GnRH 100 micrograms at time 0 plus IV infusion of porcine galanin 500 micrograms in 100 mL saline from -10 to +30 minutes
Number of subjects: 13
Study 7543651 — intervention group
Group type: COMPARATOR
Intervention: GHRH (1-29)NH2 1 microgram/kg plus GnRH 100 micrograms at time 0
Number of subjects: 13
Study 7543651 — intervention group
Group type: COMPARATOR
Intervention: GnRH
Number of subjects: 13
Study 2615925 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg WEB 1881 FU
Number of subjects: 0
Study 2615925 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg WEB 1881 FU
Number of subjects: 0
Study 2615925 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 350265 — intervention group
Group type: EXPERIMENTAL
Intervention: Guanethidine 3% and adrenaline 0.5%
Number of subjects: 0
Study 350265 — intervention group
Group type: COMPARATOR
Intervention: Adrenaline 1%
Number of subjects: 0
Study 30870087 — intervention group
Group type: EXPERIMENTAL
Intervention: Structural intervention refocusing government support programs for young women
Number of subjects: 0
Study 30870087 — intervention group
Group type: EXPERIMENTAL
Intervention: Social network analysis
Number of subjects: 0
Study 30870087 — intervention group
Group type: EXPERIMENTAL
Intervention: Ego-centric and sociometric analyses
Number of subjects: 0
Study 29783025 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose trivalent inactivated influenza vaccine (HDTIV)
Number of subjects: 47
Study 28758311 — intervention group
Group type: EXPERIMENTAL
Intervention: Protected arm condition
Number of subjects: 32
Study 28758311 — intervention group
Group type: COMPARATOR
Intervention: Unprotected arm condition
Number of subjects: 32
Study 28758311 — intervention group
Group type: COMPARATOR
Intervention: Neutral arm condition
Number of subjects: 32
Study 28758311 — intervention group
Group type: COMPARATOR
Intervention: Skin conductance level (SCL) measurements for all arm types
Number of subjects: 32
Study 25027444 — intervention group
Group type: EXPERIMENTAL
Intervention: Alexander Technique lessons
Number of subjects: 120
Study 25027444 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 120
Study 23585346 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 IU vitamin D3
Number of subjects: 305
Study 23585346 — intervention group
Group type: COMPARATOR
Intervention: 400 IU vitamin D3
Number of subjects: 305
Study 23585346 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 305
Study 21428726 — intervention group
Group type: EXPERIMENTAL
Intervention: fesoterodine 4 mg
Number of subjects: 1013
Study 21428726 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1013
Study 19695283 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance-tailored therapy (MTT)
Number of subjects: 213
Study 19695283 — intervention group
Group type: COMPARATOR
Intervention: Standard behavior therapy (SBT)
Number of subjects: 213
Study 16929238 — intervention group
Group type: EXPERIMENTAL
Intervention: Chilli diet (30 g/day of a chilli blend with 55% cayenne chilli)
Number of subjects: 36
Study 16929238 — intervention group
Group type: EXPERIMENTAL
Intervention: Chilli diet
Number of subjects: 36
Study 16929238 — intervention group
Group type: COMPARATOR
Intervention: Bland diet
Number of subjects: 36
Study 16929238 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyceryl-trinitrate (GTN) and salbutamol
Number of subjects: 36
Study 15502057 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouth-to-bag resuscitator
Number of subjects: 40
Study 15502057 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic pressure-controlled ventilation
Number of subjects: 40
Study 15502057 — intervention group
Group type: COMPARATOR
Intervention: Pediatric self-inflating bag ventilation
Number of subjects: 40
Study 11255386 — intervention group
Group type: EXPERIMENTAL
Intervention: MBL-insufficient children (n=13)
Number of subjects: 252
Study 11255386 — intervention group
Group type: EXPERIMENTAL
Intervention: Children aged 6 to 17 months (n=13)
Number of subjects: 252
Study 11255386 — intervention group
Group type: COMPARATOR
Intervention: Children aged 0 to 5 months
Number of subjects: 252
Study 11255386 — intervention group
Group type: COMPARATOR
Intervention: Children aged 18 to 23 months
Number of subjects: 252
Study 9631311 — intervention group
Group type: COMPARATOR
Intervention: Lansoprazole 30 mg daily and amoxicillin 500 mg three times a day for 14 days (LA)
Number of subjects: 65
Study 9631311 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg daily and amoxicillin 500 mg three times a day for 14 days plus miconazole gel 100 mg three times a day for 14 days (LAM)
Number of subjects: 65
Study 8153231 — intervention group
Group type: EXPERIMENTAL
Intervention: Heterosexually cued behaviors
Number of subjects: 0
Study 8153231 — intervention group
Group type: EXPERIMENTAL
Intervention: Homosexually cued behaviors
Number of subjects: 0
Study 8153231 — intervention group
Group type: COMPARATOR
Intervention: No cues
Number of subjects: 0
Study 3244616 — intervention group
Group type: EXPERIMENTAL
Intervention: Heidelberg capsule (HC) ingestion after a standardized 500-kcal breakfast in males
Number of subjects: 36
Study 3244616 — intervention group
Group type: COMPARATOR
Intervention: Heidelberg capsule (HC) ingestion in supine posture
Number of subjects: 36
Study 3244616 — intervention group
Group type: EXPERIMENTAL
Intervention: Heidelberg capsule (HC) ingestion in elderly males (greater than 65 years)
Number of subjects: 36
Study 29204959 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate for 10 years (Continuously treated group)
Number of subjects: 31
Study 29204959 — intervention group
Group type: COMPARATOR
Intervention: Alendronate for 5 years followed by a 5-year holiday (Discontinued group)
Number of subjects: 31
Study 28969659 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 20 mg/kg/day (maximum 1000 mg/day) in a single daily dose
Number of subjects: 330
Study 28969659 — intervention group
Group type: COMPARATOR
Intervention: Co-trimoxazole 60 mg/kg/day (maximum 3000 mg/day) in two divided doses
Number of subjects: 330
Study 26585952 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (1200 IU daily)
Number of subjects: 155
Study 26585952 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155
Study 24499609 — intervention group
Group type: EXPERIMENTAL
Intervention: SBIRT intervention for low or medium risk offenders, including brief intervention and referral to community treatment for high risk offenders.
Number of subjects: 800
Study 24499609 — intervention group
Group type: COMPARATOR
Intervention: Minimal intervention for control group.
Number of subjects: 800
Study 22031659 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose plant-derived (n-3) fatty acids (2.2 g/d α-linolenic acid)
Number of subjects: 100
Study 22031659 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose plant-derived (n-3) fatty acids (6.6 g/d α-linolenic acid)
Number of subjects: 100
Study 22031659 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose marine-derived (n-3) fatty acids (1.2 g/d EPA and DHA)
Number of subjects: 100
Study 22031659 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose marine-derived (n-3) fatty acids (3.6 g/d EPA and DHA)
Number of subjects: 100
Study 22031659 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 22031659 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose fish oil
Number of subjects: 100
Study 18652090 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenotonsillectomy followed by orthodontic expansion
Number of subjects: 32
Study 18652090 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthodontic treatment followed by adenotonsillectomy
Number of subjects: 32
Study 18652090 — intervention group
Group type: EXPERIMENTAL
Intervention: Both therapies (adenotonsillectomy and orthodontic expansion)
Number of subjects: 32
Study 16410460 — intervention group
Group type: EXPERIMENTAL
Intervention: rosiglitazone (4 mg BID)
Number of subjects: 24
Study 12612145 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet A (24 mg Met/(kg. d) and no Cys)
Number of subjects: 5
Study 12612145 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet B (13 mg Met/(kg. d) and 11 mg Cys/(kg. d))
Number of subjects: 5
Study 12612145 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet C (5 mg Met/(kg. d) and 19 mg Cys/(kg. d))
Number of subjects: 5
Study 10905679 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone antibiotic prophylaxis
Number of subjects: 224
Study 10905679 — intervention group
Group type: COMPARATOR
Intervention: No prophylaxis (Control)
Number of subjects: 224
Study 9143072 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin 1 mg
Number of subjects: 8
Study 9143072 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin 10 mg
Number of subjects: 8
Study 9143072 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin 40 mg
Number of subjects: 8
Study 9143072 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (all doses)
Number of subjects: 8
Study 9143072 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 7973429 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraluminal impedance measuring
Number of subjects: 20
Study 2514318 — intervention group
Group type: EXPERIMENTAL
Intervention: rt‐PA (60 mg over 90 minutes i.v.)
Number of subjects: 27
Study 2514318 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 181193 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate, 0.3 gm every 8 hr
Number of subjects: 18
Study 181193 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 18
Study 28350809 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-session family-based intervention delivered to groups of families by lay facilitators
Number of subjects: 479
Study 25790742 — intervention group
Group type: EXPERIMENTAL
Intervention: Plastic stents
Number of subjects: 219
Study 25790742 — intervention group
Group type: EXPERIMENTAL
Intervention: uSEMS
Number of subjects: 219
Study 25790742 — intervention group
Group type: EXPERIMENTAL
Intervention: pcSEMS
Number of subjects: 219
Study 25790742 — intervention group
Group type: EXPERIMENTAL
Intervention: SEMS (uSEMS and pcSEMS)
Number of subjects: 219
Study 21879354 — intervention group
Group type: EXPERIMENTAL
Intervention: Early go-signal for hand-related nouns
Number of subjects: 0
Study 21879354 — intervention group
Group type: EXPERIMENTAL
Intervention: Early go-signal for foot-related nouns
Number of subjects: 0
Study 21879354 — intervention group
Group type: EXPERIMENTAL
Intervention: Early go-signal for left hand
Number of subjects: 0
Study 21787499 — intervention group
Group type: EXPERIMENTAL
Intervention: RealSeal + gutta‐percha
Number of subjects: 40
Study 21787499 — intervention group
Group type: EXPERIMENTAL
Intervention: RealSeal + Resilon
Number of subjects: 40
Study 21787499 — intervention group
Group type: COMPARATOR
Intervention: Exponential polymerization mode
Number of subjects: 40
Study 21787499 — intervention group
Group type: COMPARATOR
Intervention: Standard polymerization mode
Number of subjects: 40
Study 19405832 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal treatment
Number of subjects: 22
Study 19405832 — intervention group
Group type: COMPARATOR
Intervention: Control group (delayed treatment for 3 months)
Number of subjects: 22
Study 17078435 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical acupuncture and auricular-plaster therapy
Number of subjects: 64
Study 17078435 — intervention group
Group type: COMPARATOR
Intervention: Oral hydrocortisone
Number of subjects: 64
Study 15291662 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine extended-release (XR)
Number of subjects: 1932
Study 15291662 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1932
Study 15291662 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine XR
Number of subjects: 1932
Study 11207517 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin 500 mg b.d. (OABC group)
Number of subjects: 118
Study 11207517 — intervention group
Group type: EXPERIMENTAL
Intervention: Furazolidone 200 mg b.d. (OABF group)
Number of subjects: 118
Study 8588060 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan/Large Neutral Amino Acids ratio
Number of subjects: 0
Study 8588060 — intervention group
Group type: EXPERIMENTAL
Intervention: Tyrosine/Large Neutral Amino Acids ratio
Number of subjects: 0
Study 1665116 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 7180724 — intervention group
Group type: EXPERIMENTAL
Intervention: Active diuretic therapy
Number of subjects: 77
Study 7180724 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 30707731 — intervention group
Group type: EXPERIMENTAL
Intervention: Private time preference
Number of subjects: 650
Study 30707731 — intervention group
Group type: EXPERIMENTAL
Intervention: Social time preference
Number of subjects: 650
Study 30707731 — intervention group
Group type: EXPERIMENTAL
Intervention: Discounted utility model assumptions
Number of subjects: 650
Study 28711115 — intervention group
Group type: EXPERIMENTAL
Intervention: Group cognitive behavioral therapy (CBT)
Number of subjects: 116
Study 26458907 — intervention group
Group type: EXPERIMENTAL
Intervention: Oropharyngeal administration of mother's milk (0.2 mL every 2 hours for 48 hours, then every 3 hours until 32 weeks corrected-gestational age)
Number of subjects: 622
Study 26458907 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.2 mL sterile water every 2 hours for 48 hours, then every 3 hours until 32 weeks corrected-gestational age)
Number of subjects: 622
Study 23842828 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty (PTA)
Number of subjects: 112
Study 23842828 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary iliac stent placement
Number of subjects: 112
Study 21332400 — intervention group
Group type: EXPERIMENTAL
Intervention: STPG treatment (4 capsules, 2g)
Number of subjects: 14
Study 19541291 — intervention group
Group type: EXPERIMENTAL
Intervention: Lutein, zeaxanthin and blackcurrant extract (LUT) supplement
Number of subjects: 13
Study 19541291 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 18427455 — intervention group
Group type: EXPERIMENTAL
Intervention: Stalevo (levodopa/carbidopa/entacapone)
Number of subjects: 0
Study 18427455 — intervention group
Group type: COMPARATOR
Intervention: Traditional therapy
Number of subjects: 0
Study 14740240 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (40 mg/day)
Number of subjects: 22
Study 14740240 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 11426007 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser Doppler imaging
Number of subjects: 0
Study 11426007 — intervention group
Group type: COMPARATOR
Intervention: Power Doppler sign
Number of subjects: 0
Study 9608790 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine + lidocaine (30 mg of bupivacaine plus 240 mg of lidocaine)
Number of subjects: 30
Study 9608790 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine (300 mg)
Number of subjects: 30
Study 10048652 — intervention group
Group type: EXPERIMENTAL
Intervention: Children's hand cleanser
Number of subjects: 40
Study 10048652 — intervention group
Group type: EXPERIMENTAL
Intervention: Industrial hand cleansers
Number of subjects: 40
Study 10048652 — intervention group
Group type: COMPARATOR
Intervention: Emollient
Number of subjects: 40
Study 2695646 — intervention group
Group type: EXPERIMENTAL
Intervention: Light support pantyhose
Number of subjects: 0
Study 831706 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide plus staging
Number of subjects: 35
Study 831706 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 31838334 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-Led Total Sanitation (CLTS)
Number of subjects: 3216
Study 31838334 — intervention group
Group type: EXPERIMENTAL
Intervention: RANAS-based interventions
Number of subjects: 3216
Study 31838334 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 3216
Study 30234839 — intervention group
Group type: EXPERIMENTAL
Intervention: Inferior turbinate fracture combined with first probing
Number of subjects: 176
Study 30234839 — intervention group
Group type: COMPARATOR
Intervention: Simple probing without inferior turbinate fracture
Number of subjects: 176
Study 30234839 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined case and control groups (younger than 24 months)
Number of subjects: 176
Study 30234839 — intervention group
Group type: COMPARATOR
Intervention: Combined case and control groups (older than 24 months)
Number of subjects: 176
Study 27541827 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 monoclonal antibodies (SP142, E1L3N, 9A11, SP263, 22c3, and 28-8)
Number of subjects: 30
Study 26437899 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential amino acids (EAAs) 8 g/d
Number of subjects: 42
Study 26437899 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric maltodextrin (placebo)
Number of subjects: 42
Study 23452996 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrow acquisition (NA)
Number of subjects: 205
Study 23452996 — intervention group
Group type: COMPARATOR
Intervention: Widened acquisition (WA)
Number of subjects: 205
Study 20579849 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C 500 mg/d
Number of subjects: 16
Study 20579849 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C 100 mg/d
Number of subjects: 16
Study 19425829 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.0-microm droplets
Number of subjects: 15